A detailed history of Susquehanna International Group, LLP transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 150,975 shares of CLPT stock, worth $2.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
150,975
Previous 74,567 102.47%
Holding current value
$2.35 Million
Previous $401,000 321.95%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.3 - $13.18 $404,962 - $1.01 Million
76,408 Added 102.47%
150,975 $1.69 Million
Q2 2024

Aug 15, 2024

BUY
$5.25 - $6.73 $260,578 - $334,036
49,634 Added 199.07%
74,567 $401,000
Q1 2024

May 07, 2024

BUY
$6.03 - $7.86 $43,838 - $57,142
7,270 Added 41.16%
24,933 $169,000
Q4 2023

Feb 14, 2024

BUY
$4.46 - $7.07 $78,776 - $124,877
17,663 New
17,663 $119,000
Q2 2023

Aug 11, 2023

SELL
$6.54 - $10.58 $812,411 - $1.31 Million
-124,222 Reduced 84.13%
23,425 $169,000
Q1 2023

May 16, 2023

BUY
$7.33 - $10.63 $139,819 - $202,767
19,075 Added 14.84%
147,647 $1.25 Million
Q4 2022

Feb 14, 2023

BUY
$7.7 - $11.21 $800,599 - $1.17 Million
103,974 Added 422.69%
128,572 $1.09 Million
Q3 2022

Nov 14, 2022

BUY
$9.82 - $16.49 $241,552 - $405,621
24,598 New
24,598 $255,000
Q1 2022

May 16, 2022

SELL
$7.8 - $11.6 $318,107 - $473,082
-40,783 Reduced 64.8%
22,152 $231,000
Q4 2021

Feb 14, 2022

SELL
$11.08 - $18.86 $135,563 - $230,752
-12,235 Reduced 16.28%
62,935 $706,000
Q3 2021

Nov 15, 2021

SELL
$16.58 - $22.25 $696,558 - $934,767
-42,012 Reduced 35.85%
75,170 $1.33 Million
Q2 2021

Aug 11, 2021

BUY
$17.23 - $22.77 $472,567 - $624,512
27,427 Added 30.56%
117,182 $2.24 Million
Q1 2021

May 17, 2021

BUY
$15.19 - $29.0 $1.36 Million - $2.6 Million
89,755 New
89,755 $1.9 Million

Others Institutions Holding CLPT

About ClearPoint Neuro, Inc.


  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $381M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.